Carcinogenesis Advance Access originally published online on June 15, 2006
Carcinogenesis 2006 27(12):2519-2527; doi:10.1093/carcin/bgl103
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk
Lineberger Comprehensive Cancer Center, Center for Environmental Health and Susceptibility, Department of Pathology and Laboratory Medicine, Department of Biostatistics, Department of Epidemiology and Department of Medicine, University of North Carolina at Chapel Hill Chapel Hill, NC 27599, USA
*To whom correspondence should be addressed at: CB no.7295, Room 31-325 Lineberger, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7295, USA. Tel: +1 919 966 8209; Fax: +1 919 966 9673; Email: wkarlk{at}med.unc.edu
Background: Familial breast cancer is associated with mutations in several genes (BRCA1, BRCA2, p53, ATM) whose protein products protect against radiation-induced genotoxicity. This study tested whether sporadic breast cancer was associated with constitutive radiation hypersensitivity. Methods: Blood lymphocytes and EBV-transformed lymphoblasts from patients with newly diagnosed breast cancer and controls without cancer were evaluated for ionizing radiation (IR)-induced chromosomal aberrations and cell cycle delays. Lymphoblasts from patients with ataxia telangiectasia (AT) and heterozygous AT carriers were tested as positive controls for radiation hypersensitivity. Results: Lymphoblasts from AT patients and AT carriers displayed G2-irradiation, chromosomal hypersensitivity (GICH). Irradiated G2 phase lymphocytes from breast cancer cases and controls displayed 3-fold inter-individual variation in frequencies of chromatid damage. However, the percentage of breast cancer cases with damage frequencies in excess of 2 SD of the control mean (8/102 or 8%) was not significantly elevated compared to controls (2/48 or 4%, P = 0.5). Lymphoblasts sampled 24 h after 3 Gy of IR also varied in the ratios of cells with 4N and 2N DNA content (4N/2N ratio), as a measure of cell cycle checkpoint function. 4N/2N ratios in irradiated lymphoblasts were strongly correlated with the fractions of S phase cells in un-irradiated control cultures (Pearson's correlation coefficient, r = 0.87). After normalization to S fraction, the radiation-induced increment in the 4N/2N ratio was significantly elevated in AT lymphoblasts but not in lymphoblasts from AT carriers. The fraction of breast cancer cases with reduced checkpoint function (2/45 or 4%) was equal to the control fraction (2/45 or 4%). For breast cancer cases and controls, GICH in primary lymphocytes was not associated with reduced cell cycle checkpoint function in lymphoblasts. Conclusion: Constitutive radiation hypersensitivity in blood lymphocytes and lymphoblasts was not a useful biomarker for identifying women at increased risk of breast cancer.